Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: July 18, 2018

DrugPatentWatch Database Preview

Kyowa Kirin Company Profile

« Back to Dashboard

What is the competitive landscape for KYOWA KIRIN, and when can generic versions of KYOWA KIRIN drugs launch?

KYOWA KIRIN has two approved drugs.

There is one US patent protecting KYOWA KIRIN drugs.

There are thirty-seven patent family members on KYOWA KIRIN drugs in thirty-one countries and one supplementary protection certificate in one country.

Summary for Kyowa Kirin

International Patents:	37
US Patents:	1
Tradenames:	2
Ingredients:	2
NDAs:	2

Drugs and US Patents for Kyowa Kirin

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Kyowa Kirin	FARESTON	toremifene citrate	TABLET;ORAL	020497-001	May 29, 1997		RX	Yes	Yes		➤ Try a Free Trial				➤ Try a Free Trial
Kyowa Kirin	SANCUSO	granisetron	FILM, EXTENDED RELEASE;TRANSDERMAL	022198-001	Sep 12, 2008		RX	Yes	Yes	7,608,282	➤ Try a Free Trial	Y			➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for Kyowa Kirin

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Kyowa Kirin	FARESTON	toremifene citrate	TABLET;ORAL	020497-001	May 29, 1997	4,696,949	➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Paragraph IV (Patent) Challenges for KYOWA KIRIN drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Transdermal System	3.1 mg/24 hrs	➤ Subscribe	2015-10-09

International Patents for Kyowa Kirin Drugs

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration
Germany	602004007888	➤ Try a Free Trial
China	102416009	➤ Try a Free Trial
Austria	368454	➤ Try a Free Trial
Georgia, Republic of	P20084390	➤ Try a Free Trial
Country	Document Number	Estimated Expiration

Supplementary Protection Certificates for Kyowa Kirin Drugs

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C0029	Belgium	➤ Try a Free Trial	PRODUCT NAME: TOREMIFENE; REGISTRATION NO/DATE: EU/1/96/004/001 19960215
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Kyowa Kirin

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey

Julphar

Moodys

Citi

Boehringer Ingelheim

Covington

Fish and Richardson

Deloitte

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.